Director, Competitive Intelligence

At Genmab, we are dedicated to building extraordinary futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

We are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Director of Competitive Intelligence

About Us

Genmab is an international biotechnology company dedicated to the invention and development of differentiated human antibody therapeutics for the treatment of cancer and other serious diseases. Our mission is to improve the lives of patients by creating and developing innovative and differentiated antibody products, with a commitment to bringing them to market.

The Role

We are seeking a Director of Competitive Intelligence (CI) to lead the development, integration, and execution of strategic intelligence capabilities across Genmab's global oncology portfolio. In this critical role, you will act as a strategic advisor and insight generator—delivering timely, actionable competitive insights that shape commercial, clinical, and R&D decision-making.

You will lead high-impact initiatives across pipeline and marketed assets (e.g., Epkinly, Acasunlimab, and Rina-S) and develop CI capabilities and processes that scale across functions, regions, and stages of development. Reporting to the Global Head of Business Insights & Analytics, you will serve as a cross-functional collaborator and key voice in strategy development.

Key Responsibilities

Strategic Leadership :

• Develop and execute a global CI strategy aligned with brand, disease area, and portfolio objectives.
• Act as a strategic thought partner to senior leadership across Commercial, R&D, and Medical Affairs.
• Lead and manage a team (direct or matrixed) of CI professionals and vendors to deliver high-value insights.

Global Market Monitoring :

Decision Influence :

Internal Collaboration & Enablement :

Operational Excellence & Ethics :

Key Accountabilities

Portfolio & Brand Support :

Enterprise Impact :

Qualifications

Education :

Experience :

Why Join Genmab

At Genmab, our employees work with purpose and integrity to advance innovative therapies that make a meaningful difference for cancer patients. We foster an inclusive, collaborative environment built on respect, accountability, and scientific rigor.

You will join a company at the cutting edge of oncology science and help shape how we compete, adapt, and lead in a dynamic global market. This role provides a unique opportunity to work with visionary leaders, contribute to enterprise strategy, and influence the direction of our pipeline and brands.

For U.S. based candidates, the proposed salary band for this position is as follows : $188,000.00 - $282,000.00. The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.

Benefits

About You

Locations

Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are crafted as open, community-based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you're in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific.

#J-18808-Ljbffr